Document is current

Any future updates will be listed below

Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

Crossref DOI link: https://doi.org/10.1007/s00415-022-11385-4

Published Online: 2022-09-22

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark